Former executives with generic drug firms charged with anticompetitive scheme
In the first charges brought by the Justice Department’s antitrust division involving generic drugs, two ex-senior executives with generic pharmaceutical companies were charged with an anticompetitive scheme, the government said on...
Subscription required to view this article.This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: